Among the allosteric CCR9 antagonists, the most interesting are vercirnon, which has a very high selectivity for binding to CCR9 [65], and its analogs (including 4-aminopyrimidine derivatives), which may be useful in the treatment of Crohn’s disease [225]. Here, CCR9 is linked to Crohn disease.